Overview - Huarong Chemical Co., Ltd. has announced a guarantee for its wholly-owned subsidiaries, with a total guarantee amount not exceeding 284 million RMB [2][17] - The guarantee includes 150 million RMB for subsidiaries with a debt-to-asset ratio of 70% or higher and 134 million RMB for those below 70% [2] Guarantee Details - Huarong Chengdu, with a debt-to-asset ratio below 70%, has been granted a guarantee of 80 million RMB, while Huarong International, with a ratio above 70%, has a guarantee of 140 million RMB [3] - As of September 11, 2025, the company has provided guarantees of 46.12425 million RMB to Huarong Chengdu and 65 million RMB to Huarong International [3] - An asset pool financing agreement was signed with Zheshang Bank, allowing for a financing limit of up to 20 million RMB, which can be shared between the two subsidiaries [3][4] Financial and Operational Context - The guarantee period for the new guarantees is three years from the debt performance deadline [4] - The total amount of guarantees provided by the company is within the limits approved by the shareholders and board of directors, with no additional approval required [5] - The company maintains control over its subsidiaries, which are currently operating normally and have the capacity to repay their debts [15][16] Cumulative Guarantee Information - As of the announcement date, the total approved guarantee amount is 284 million RMB, with actual guarantees amounting to 111.12425 million RMB, representing 64.20% of the company's latest audited net assets [17] - The actual guarantee amount is 38.27792 million RMB, accounting for 22.11% of the company's latest audited net assets [17]

Meeting Overview - The fourth meeting of the fourth supervisory board of the company was held on August 22, 2025, in accordance with legal and regulatory requirements [1] - All three supervisors participated in the voting, with no dissenting or abstaining votes [2] Financial Reporting - The supervisory board approved the company's 2025 semi-annual report and its summary, confirming that the report accurately reflects the company's operational status without any false statements or omissions [1][2] - The report will be published on the designated information disclosure website on August 23, 2025 [2] Fund Management - The supervisory board reviewed and approved the management of the company's fundraising, confirming compliance with relevant regulations and no misuse of funds [2][3] - The semi-annual profit distribution plan was deemed compliant with legal and regulatory standards, reflecting the company's commitment to shareholder returns [2][3] Project Completion and Fund Allocation - The board agreed to conclude certain fundraising projects and permanently allocate surplus funds to working capital, aligning with regulatory requirements and supporting subsidiary operations [4][5] Foreign Exchange Derivatives - The supervisory board approved the company's and its subsidiaries' engagement in foreign exchange derivative transactions, which are seen as beneficial for financial stability and risk management [4][5] Asset Pool Business - The board consented to the company's and its subsidiaries' asset pool business, aimed at enhancing the efficiency and returns of bill assets without affecting core business operations [5][6]

Group 1 - The board of directors of Jingrui Electronic Materials Co., Ltd. held its eighth meeting of the fourth session, with all nine directors present, ensuring compliance with legal and regulatory requirements [1] - The board approved the 2025 semi-annual report and the special report on the use of raised funds, with unanimous support from all directors [2][3] - The company proposed a cash dividend of 0.10 yuan (including tax) per share based on the total share capital of 1,059,574,198 shares as of June 30, 2025, without capital reserve conversion or stock distribution [2][3] Group 2 - The board plans to hold a temporary shareholders' meeting on September 16, 2025, to review the proposals that require shareholder approval [4] - The company will adjust the total cash dividend amount if there are changes in total share capital before the implementation of the profit distribution plan, maintaining the distribution ratio [2][3]

Group 1 - The first extraordinary general meeting of shareholders for Jianmin Pharmaceutical Group Co., Ltd. is scheduled for July 30, 2025, at 14:00 in Wuhan [1][2] - The meeting will combine on-site voting and online voting through the Shanghai Stock Exchange's shareholder meeting voting system [4][7] - The agenda includes the review and voting on the proposal to amend the company's articles of association [8][9] Group 2 - The meeting will be presided over by Vice Chairman Xu Liang, with Secretary of the Board Zhou Jie recording the minutes [1][2] - Shareholders or their legal representatives must register 30 minutes before the meeting and present necessary identification [6] - The voting process will include a break, followed by the announcement of voting results after the market closes at 15:00 [2][5] Group 3 - The proposed amendments to the articles of association aim to enhance corporate governance by removing the supervisory board and transferring its responsibilities to the audit committee [8][9] - New sections will clarify the roles and obligations of controlling shareholders and actual controllers, as well as the responsibilities of independent directors [9][21] - The amendments will also standardize the procedures for convening shareholder meetings and clarify the qualifications for directors and senior management [9][10]

Group 1 - The company has approved the establishment of an asset pool business with a total limit not exceeding RMB 100 million to enhance liquidity and asset management efficiency [1][2] - The asset pool business will involve the management of various financial assets such as certificates of deposit, acceptance bills, letters of credit, financial products, and accounts receivable [2][3] - The purpose of the asset pool business is to effectively activate financial assets, reduce capital occupation, and improve the efficiency of the company's current assets, ultimately maximizing shareholder value [2][4] Group 2 - The asset pool business will be conducted with reputable domestic commercial banks, ensuring a good cooperative relationship and leveraging the banks' asset pool service capabilities [2][3] - The company will implement risk control measures, including establishing a dedicated team to manage the asset pool and conducting audits to ensure the safety and liquidity of the pooled assets [3][4] - As of the announcement date, the company's external guarantee balance is RMB 53.72 million, accounting for 11.75% of the audited total assets for 2024, with no overdue guarantees reported [3][4]

Core Viewpoint - The company plans to continue its asset pool business with Zhejiang Commercial Bank, with a credit limit of 400 million yuan and a term of 12 months from the approval of the shareholders' meeting [1][2][3] Summary by Sections Asset Pool Business Overview - The asset pool business allows the company and its subsidiaries to manage and utilize their assets collectively, providing a comprehensive service platform for asset management and financing [1][2] - The financing limit for the asset pool is set at 400 million yuan, which accounts for 16.43% of the company's latest audited net assets of 2,435.31 million yuan [2][3] Guarantee Methods and Parties Involved - The company will provide maximum pledge guarantees, utilizing various forms of collateral such as certificates of deposit, bills, and margin deposits [2][3] - The maximum financing limit for the subsidiary, Guangdong Fuga Pharmaceutical Co., Ltd., is capped at 56 million yuan, with the company assuming joint liability for guarantees [3][4] Financial Status - As of March 31, 2025, the company's total assets were 427,768.32 million yuan, with net assets of 254,548.31 million yuan and a debt-to-asset ratio of 40.15% [5] - The subsidiary, Guangdong Fuga Pharmaceutical Co., Ltd., reported total assets of 58,102.82 million yuan and net assets of 4,952.81 million yuan as of March 31, 2025 [6] Agreements and Contracts - The company intends to sign a cooperation agreement with Zhejiang Commercial Bank for the asset pool business, which includes provisions for collateral rights and various financing methods [7][8] - A guarantee agreement will be established with Guangzhou Hongshan Investment Co., Ltd., which will pledge its entire equity in Fuga Pharmaceutical as collateral for financing within the asset pool limit [8][9] Impact and Risk Control - The asset pool business is expected to enhance the efficiency of the company's bill assets, reduce financial costs, and maximize shareholder equity [9][10] - The company will implement measures to manage liquidity risks associated with the asset pool, including tracking the collection of pledged bills and ensuring timely repayments [10][11]

Core Points - The company reported a revenue of 3.068 billion yuan for the first quarter of 2025, representing a year-on-year decline of 22.3% [22] - The net profit for the same period was 9.18 million yuan, down 97.2% year-on-year, indicating a significant decrease in profitability [22] - The board of directors and management have been urged to enhance operational management, expand revenue, and control costs to improve performance and protect shareholder interests [22] Financial Data - The company confirmed that the quarterly report is accurate, complete, and free from any misleading statements or omissions [2][3] - The first quarter report was not audited [16] - The company does not have any non-recurring gains or losses to report for the quarter [3] Shareholder Information - The company has a total of 10 billion yuan registered for issuing medium-term notes and short-term financing bonds, with the latter being registered for a total of 1 billion yuan [7][9] - The company has approved a guarantee plan for 2024, with a total guarantee amount not exceeding 24.4 billion yuan [10] - The company is currently in the process of board and supervisory committee member re-election, which is not expected to adversely affect operations [13] Other Important Matters - The company has initiated a share buyback plan for both A-shares and B-shares, with the buyback period set for twelve months [14] - The company is involved in a legal case regarding a 171 million yuan talent introduction fund, currently under appeal [12]

Core Viewpoint - Great Wall Motors reported a decline in March sales and production figures, while also revealing strong annual performance for 2024, indicating a mixed outlook for the company [1][5]. Sales and Production Data - In March, Great Wall Motors sold 97,991 vehicles, a year-on-year decrease of 2.28%, and produced 100,067 vehicles, down 6.67% year-on-year [3][5]. - Breakdown of March sales by brand: - Haval: 52,732 units, down 2.45% - WEY: 4,675 units, up 29.57% - Great Wall Pickup: 20,421 units, up 16.23% - Ora: 2,776 units, down 53.90% - Tank: 17,381 units, down 8.29% [3][4]. Quarterly Performance - For Q1, total sales reached 256,807 units, a decline of 6.73% year-on-year, while total production was 257,437 units, down 2.88% year-on-year [5]. - Overseas sales in March were 31,806 units, with a cumulative total of 90,890 units for Q1 [5]. Annual Financial Performance - In 2024, Great Wall Motors achieved a revenue of 20.22 billion yuan, a year-on-year increase of 16.73%, and a net profit of 12.69 billion yuan, up 80.76% [7][8]. - The company reported a significant increase in net profit attributable to shareholders, with a growth of 101.40% in net profit excluding non-recurring items [7][8]. Dividend Distribution - The company proposed a cash dividend of 0.45 yuan per share, totaling approximately 3.85 billion yuan, which represents 30.36% of the net profit for 2024 [8][10]. Future Plans and Guarantees - For 2025, Great Wall Motors plans to provide guarantees for its subsidiaries, with a total amount not exceeding 9.5 billion yuan [11][13]. - The company also aims to engage in asset pool business with a projected limit of 24 billion yuan for 2025 [13].

长城汽车股份有限公司 会议须知 各位股东、股东授权代表： 为维护全体股东的合法权益，确保股东大会的正常秩序和议事效率，保证大会顺 利进行，长城汽车股份有限公司（以下简称"本公司"或"公司"）根据中国证券监 督管理委员会《上市公司股东大会规则》、本公司《股东大会议事规则》等文件的有 关要求，通知如下： GREAT WALL MOTOR COMPANY LIMITED A 股股票代码：601633 H 股股票代码：02333（港币柜台）及 82333（人民币柜台） 会议资料 一、参会的股东及股东授权代表须携带身份证明（身份证、股东证明文件）及相 关授权文件办理会议登记手续及有关事宜。 二、出席本次股东大会的股东及股东授权代表应于 2025 年 4 月 23 日（星期三）下 午 13:00—13:50 办理会议登记。在宣布现场出席会议的股东和股东授权代表人数及所 持有表决权的股份总数后，已提交会议出席回条但未登记的股东和股东授权代表无权参 加会议表决。 三、为保证本次大会的严肃性和正常秩序，切实维护股东的合法权益，务必请出席 现场大会的股东和股东授权代表携带相关证件，提前到达会场登记参会资格并签到。未 能提供有效证 ...

-1- 上述资产池业务的开展期限为自本年度股东大会审议通过本议案之日起至 下一年度股东大会召开之日止。 公司及子公司共享不超过 35 亿元的资产池额度，即用于与所有合作银行开 展资产池业务的质押、抵押的资产累计即期余额不超过人民币 35 亿元，业务期 限内，该额度可滚动使用。具体每笔发生额提请公司股东大会授权公司董事长 根据公司和子公司的经营需要按照系统利益最大化原则确定。 在风险可控的前提下，公司及子公司为资产池的建立和使用可采用最高额 质押、一般质押、存单质押、票据质押、保证金质押等多种担保方式。具体每 笔担保形式及金额提请公司股东大会授权公司董事长根据公司和子公司的经营 需要按照系统利益最大化原则确定。 三花智控: 关于开展资产池业务的公告 证券代码：002050 证券简称：三花智控 公告编号：2025-017 浙江三花智能控制股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 浙江三花智能控制股份有限公司（以下称"公司"）2025年3月25日召开的第 七届董事会第三十一次会议审议通过了《关于开展资产池业务的议案》，同意公 司及控股子公司共享不 ...